What's Happening?
Atrandi Biosciences has launched its new 170 µm and 300 µm SPC Innovator Kits, enhancing its portfolio for single-cell analysis. These kits are designed to encapsulate a broad range of cell types, including larger and structurally complex samples, facilitating multi-step single-cell workflows. Atrandi's patented Semi-Permeable Capsule (SPC) technology allows for sequential processing steps while maintaining cell identity, making multi-step, single-cell processing practical at scale. The kits support applications across immunology, oncology, developmental biology, and synthetic biology, enabling researchers to perform high-throughput single-cell assays and optimize molecular workflows.
Why It's Important?
The expansion of Atrandi's SPC Innovator Kit portfolio represents
a significant advancement in single-cell analysis, offering researchers the tools to conduct complex experiments with greater depth and scale. This technology addresses the limitations of traditional single-cell compartments, which are often fragile in multi-step workflows. By enabling true multi-step processing, Atrandi's SPCs facilitate the exploration of new biological questions and accelerate discovery in various fields. The ability to maintain compartmentalization of cells and nucleic acids is crucial for advancing research in areas like cancer and immunology.
What's Next?
Atrandi will showcase its latest advances in SPC technology at the AGBT 2026 General Meeting. The company plans to continue supporting researchers worldwide with its SPCs, workflow kits, and instruments, aiming to empower scientists to generate and act on new biological data. The integration of SPCs across cell types and experimental designs is expected to unlock new opportunities in single-cell multiomics, further advancing the field of life sciences.
